By proceeding, you agree to our Terms of Use and Privacy Policy.
Advances in harnessing the immune system for therapeutic development have resulted in a robust pipeline of immuno-oncology therapies and novel combinations. A successful program requires appropriate models and tools for preclinical evaluation and effective strategies for translation. Our expert speakers will discuss choosing the right preclinical model for assessing safety and efficacy, which models are best for recapitulating the tumor microenvironment, how to progress efficiently to clinical development, and the advantages of collaboration to drive innovation. Please join Cambridge Healthtech Institute’s 8th Annual Preclinical and Translational Immuno-Oncology meeting to explore innovative strategies to facilitate translation to the clinic.
Gain valuable insights into preclinical immuno-oncology research.
Deepen your understanding of preclinical immuno-oncology through engaging presentations, panel discussions, and scientific sessions and stay at the forefront.
Engage in hands-on workshops, interactive poster sessions, and networking opportunities with thought leaders, expanding your professional network in the field.
Learn from leaders' experiences, success stories, and breakthrough discoveries, and ignite your passion for advancing preclinical immuno-oncology.
Cambridge Healthtech Institute – Your Life Science Network Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations.
Biocytogen provides integrated solutions for next-generation antibody drug development to the global biomedical communities.
Our mission is to deliver innovative drugs to the broader population of patients worldwide at reasonable cost. FUJIFILM Pharmaceuticals U.S.A., Inc. started its operation in 2008 as FUJIFILM’s global center for new drug development.
Sanyou Biopharmaceuticals Co., Ltd. is a leading international biological high-tech enterprise focusing on R&D and services of innovative antibody drugs.
The CDMO segment of the world's leading biotech company GenScript.
Telesis Bio is empowering researchers to accelerate the creation of novel synthetic biology solutions to address some of humanity’s greatest challenges.
The OmniAb discovery platform provides pharmaceutical industry partners access to diverse antibody repertoires and high-throughput screening technologies to enable discovery of next-generation therapeutics.
Selvita is one of the largest preclinical contract research organizations in Europe, driven by a clear mission: to offer a comprehensive scope of services bridging the gap between early drug discovery and the clinical stage of drug development.
Nona Biosciences is a global biotechnology company committed to providing a total solution for partners worldwide, from academies, biotech startups to biopharma giants. The integrated antibody discovery services range from antigen preparation, animal
Nona Biosciences is a global biotechnology company committed to providing a total solution for partners worldwide, from academies, biotech startups to biopharma giants. The integrated antibody discovery services range from antigen preparation, animal immunization, single B cell screening, to antibod
BostonGene Corporation is pioneering the use of biomedical software for advanced patient analysis and personalized therapy decision making in the fight against cancer. BostonGene’s unique solution performs sophisticated analytics to aid clinicians in
BostonGene Corporation is pioneering the use of biomedical software for advanced patient analysis and personalized therapy decision making in the fight against cancer. BostonGene’s unique solution performs sophisticated analytics to aid clinicians in their evaluation of viable treatment options for
NeoSome Life Sciences is a PreClinical Research Organization providing in life modeling for several therapeutic research areas. We offer a range of services from Proof of Concept to IND enabling studies. Our specialties include Infectious Diseases, O
NeoSome Life Sciences is a PreClinical Research Organization providing in life modeling for several therapeutic research areas. We offer a range of services from Proof of Concept to IND enabling studies. Our specialties include Infectious Diseases, Oncology, Toxicology, and General Pharmacology.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.